![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.235 | -4.94% | 4.52 | 4.35 | 4.69 | 4.75 | 4.36 | 4.75 | 212,429 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.50 | 9.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/4/2020 08:21 | And right on time sellers arrive to curb any rise. Grrrrrr. | ![]() cambradjones | |
30/4/2020 08:11 | Being saying that all week. SNG likes Thursdays | ![]() vitec | |
30/4/2020 08:10 | From my point of view as an investment the risk has been considerably reduced. Home treatment should show the best results catching the illness early and expands the market size. | ![]() pdt | |
30/4/2020 08:09 | Nicely out the starting blocks today!! | ![]() mostro | |
30/4/2020 08:04 | Thurs and Fridays are our "up days" ! | ![]() cambradjones | |
30/4/2020 08:04 | Good to see Floyd/Likya making friends on the other site 🤣 Sharesting ramping like mad... Panic with all those on big losses.. Trial extended and all those gambling can't wait.. Lansdowne still selling millons... This is going down lots more. | ![]() adman50 | |
30/4/2020 05:57 | Just caught up on over 160 posts. Re: Voting to ban Likya = Already filtered but banning would reduce extra noise. To - BMNSA I hope you daughter recovers soon! Re: SNG - The most important part, assuming all is still going to plan, from the piece below linked to already is this part: Post the outbreak of COVID-19, which started from the mainland of China and till now has gripped almost every country on this planet. The company has been approached by several other medical, scientific, and governmental bodies in the UK, US and other nations. It is presently in discussion with them who are seeking to investigate novel therapeutics in this area. | ![]() lauders | |
30/4/2020 00:48 | They said they managed to reduce hospitalization from 14 days to 11. Thought I heard him say 30% and laughed its only 20 Although 3 days in an American hospital is probably $4k | ![]() bobaxe1 | |
29/4/2020 23:40 | They may try bleach yet, it kills everything on a beach in spain. | ![]() royalalbert | |
29/4/2020 23:34 | I've just read an article on BBC news about Remdesivir being a "clear cut" solution ( according to the yanks). It then goes on to question it's benefits, the EU health chiefs are reluctant to agree citing much more research needing to be conducted, the Chinese state it had zero affect and it's not considered the "magic bullet"They have no idea on what the supposed benefits are nor what age, gender or condition and state scientists do not know if the declared improvements in mortality rates are real!!Crazy! | ![]() dovey21 | |
29/4/2020 23:10 | Worth reading the amendment dated today, looks good. hxxps://www.hra.nhs. | ![]() royalalbert | |
29/4/2020 23:07 | I don't mind waiting by any stretch it's been long enough for me already lol but its all about expectation management for the next 4-6 weeks so if that trajectory has changed it's good to be ahead of it. | ![]() adman50 | |
29/4/2020 22:54 | listen to the RM You Tube interview again its all there | thwarnts | |
29/4/2020 22:48 | The important thing is that the trial is being extended. If at stage one the results were poor then the trial wouldn't be being extended. Hopefully that's the good news | ![]() serious2304 | |
29/4/2020 22:37 | If this trial is being extended to home is it a fair assumption the overall trial results are going to be delayed or are the results mutually exclusive? | ![]() adman50 | |
29/4/2020 22:12 | BBC News now - good report, but again no mention of anything that hinted at SNG. From 12 mins in if you watch on catch up later | ![]() makendon | |
29/4/2020 22:03 | Good news!... I heard that from a someone in this field. It's why I'm invested here as well as the enormous benefit this could/will provide sufferers. It's a safe medication and treatment with huge life changing potential. Superb. | ![]() dovey21 | |
29/4/2020 21:46 | WetD, the good news is that these days the markets treat Trumps statements as they would Kim Jong Un's. Very few will be convinced by the Tub-thumping. | ![]() hairballradical | |
29/4/2020 21:42 | aquilla, Didn’t mean to suggest that Gilead were any nearer to a safe/efficacious treatment, just that America under Trump look after their own ‘Make America great again’ etc etc. US Pharma cos exercise enormous leverage on the Administration and possibly the FDA to give them priority in marginal cases. Political donations and stock market performance of course have nothing to do with it... ;-) | ![]() wetdream | |
29/4/2020 21:26 | thanx serious.a very good read! | ![]() abbynat | |
29/4/2020 21:09 | https://www.hra.nhs. | ![]() serious2304 | |
29/4/2020 21:05 | Waterloo summed it up. The earlier in the paradigm you treat the more patients there are which will use your drug. It was in the original protocol anyway so it should come as no surprise to anyone. | ![]() nobbygnome | |
29/4/2020 20:26 | lol. Shows how desperate everyone is for any glimmer of 'good' news. Works in SNG favour as what might have been, so so results, will be treated with joy. The trial extension is excellent news IMO. It's not necessarily about numbers but in a different setting, and presumably earlier in the treatment cycle. | ![]() waterloo01 | |
29/4/2020 20:19 | Gilead change of heart is just trump flexing his muscles and demanding it be approved regardless of the result so he can try and save his economy, which was a massive bubble before COVID... once everyone starts growing a third nipple on their forehead he might have to pull the plug. Good luck to them though..! | lmff1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions